Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
TauRx Therapeutics Achieves Enrolment Target for Second Phase III Clinical Trial of LMTX™ in Alzheimer's Disease 2014-09-22 08:00
New Xultophy® (IDegLira) Data Show Rapid and Predictable Glycaemic Improvements in People with Type 2 Diabetes 2014-09-19 21:33
Merck Serono Awards Grant for Growth Innovation (GGI) for the First Time 2014-09-19 15:30
Merck Strengthens Executive Board 2014-09-19 01:56
Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine 2014-09-17 02:10
First European Patients Enrolled in QT Vascular's ENDURE Trial 2014-09-16 01:46
Alchem International Commits to Tropane Alkaloid APIs and Extends Production and Regulatory Support to Resolve Supply Gap 2014-09-15 09:00
Merck Discontinues Clinical Development Program of Tecemotide as a Monotherapy in Stage III Non-Small Cell Lung Cancer 2014-09-12 22:47
Kinex Completes Acquisition of QuaDPharma 2014-09-09 23:40
CPhI Korea 2014 Ends with a Great Success! 2014-09-08 20:55
Frost & Sullivan Recognizes DSM Biomedical's Outstanding Growth as a 'Total Solutions' Provider in the Medical Device Coatings Market 2014-09-08 20:00
New Platforms Enhance AMRI's Discovery Biology Offerings 2014-09-04 20:00
First Tele-health Programme for Heart Failure Patients in Singapore Enables Patients to Better Manage their Health and Reduce Hospitalisation 2014-09-04 17:14
New Data Presented at WCCS Confirm High Long-term Efficacy of Picato® in Patients with Actinic Keratosis 2014-09-04 14:00
Merck Announces Detailed 26-Week Results from Phase IIIb Study with Kuvan in Children with PKU Below 4 Years of Age 2014-09-03 21:33
Shanghai Pharmaceuticals Achieves Double-Digit Growth of Revenue and Profit for 1H2014 2014-08-30 00:07
Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2014-08-29 01:16
CAIDE Looks into the Future: New App from Merz Pharmaceuticals Assesses the Risk of Getting Dementia Within the Next 20 Years 2014-08-29 00:24
CPhI & P-MEC China 2014 Event Achieved its Grand Closing 2014-08-26 09:00
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 2014-08-23 04:17
1 407 408 409 410 411 412